Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seitz

Showing results (111-120 of 386) with videos related to

Pageof 39
Sort By:
American Journal of Medical Genetics. Part A|January 7, 2004
Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndromeSulagna C Saitta, Stacy E Harris, Donna M McDonald-McGinn, et al.
Journal of Clinical Medicine|May 13, 2026
Efficacy and Safety of Vilaprisan in the Treatment of Uterine Fibroids: Data from ASTEROID 5, a Phase 3 Multicenter Randomized Controlled TrialK Gemzell-Danielsson, C-H Cho, P Vadász, et al.
The Journal of Urology|October 5, 2001
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?B Djavan, V Ravery, A Zlotta, et al.
Cancer Immunology, Immunotherapy : CII|September 24, 2023
Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)A-M Arendt, F Heubach, C P Maier, et al.
Plos Pathogens|June 12, 2013
Crosstalk between the circadian clock and innate immunity in ArabidopsisChong Zhang, Qiguang Xie, Ryan G Anderson, et al.
Science (New York, N.Y.)|October 5, 2016
A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reactionLinsey C Seitz, Colin F Dickens, Kazunori Nishio, et al.
Blood|May 24, 2012
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseDaniel J Dairaghi, Babatunde O Oyajobi, Anjana Gupta, et al.
Nature Communications|June 13, 2019
LUX ARRHYTHMO mediates crosstalk between the circadian clock and defense in ArabidopsisChong Zhang, Min Gao, Nicholas C Seitz, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2017
Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation studyR Mathieu, M Moschini, B Beyer, et al.
Journal of Pediatric Urology|February 12, 2022
Treatment outcomes of bladder stones in children with intact bladders in developing countries: A systematic review of >1000 cases on behalf of the European Association of Urology Bladder Stones Guideline panelN F Davis, J F Donaldson, R Shepherd, et al.
Pageof 39

Showing results (111-120 of 386) with videos related to

Sort By:
Pageof 39
American Journal of Medical Genetics. Part A|January 7, 2004
Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndromeSulagna C Saitta, Stacy E Harris, Donna M McDonald-McGinn, et al.
Journal of Clinical Medicine|May 13, 2026
Efficacy and Safety of Vilaprisan in the Treatment of Uterine Fibroids: Data from ASTEROID 5, a Phase 3 Multicenter Randomized Controlled TrialK Gemzell-Danielsson, C-H Cho, P Vadász, et al.
The Journal of Urology|October 5, 2001
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?B Djavan, V Ravery, A Zlotta, et al.
Cancer Immunology, Immunotherapy : CII|September 24, 2023
Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)A-M Arendt, F Heubach, C P Maier, et al.
Plos Pathogens|June 12, 2013
Crosstalk between the circadian clock and innate immunity in ArabidopsisChong Zhang, Qiguang Xie, Ryan G Anderson, et al.
Science (New York, N.Y.)|October 5, 2016
A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reactionLinsey C Seitz, Colin F Dickens, Kazunori Nishio, et al.
Blood|May 24, 2012
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseDaniel J Dairaghi, Babatunde O Oyajobi, Anjana Gupta, et al.
Nature Communications|June 13, 2019
LUX ARRHYTHMO mediates crosstalk between the circadian clock and defense in ArabidopsisChong Zhang, Min Gao, Nicholas C Seitz, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2017
Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation studyR Mathieu, M Moschini, B Beyer, et al.
Journal of Pediatric Urology|February 12, 2022
Treatment outcomes of bladder stones in children with intact bladders in developing countries: A systematic review of >1000 cases on behalf of the European Association of Urology Bladder Stones Guideline panelN F Davis, J F Donaldson, R Shepherd, et al.
Pageof 39